Status:
TERMINATED
Multifocal Electrophysiologic Findings After Intravitreal Bevacizumab(Avastin)Treatment
Lead Sponsor:
Asociación para Evitar la Ceguera en México
Conditions:
Diabetic Proliferative Retinopathy
Vascular Vein Oclussion
Eligibility:
All Genders
Phase:
PHASE2
PHASE3
Brief Summary
Purpose: Determine the short-term safety of intravitreal bevacizumab by multifocal electroretinography (mf-ERG). Methods: 120 eyes with choroidal neovascularization, proliferative diabetic retinopath...
Eligibility Criteria
Inclusion
- Proliferative diabetic retinopathy, vascular vein oclussion, choroidal neovascularization
- Multifocal electroretinogram before intravitreal bevacizumab and at 1,3, and 6 months after treatment
- Completely studies
Exclusion
- Complications
- Tractional Detachment
- Endophthalmitis
Key Trial Info
Start Date :
December 1 2005
Trial Type :
INTERVENTIONAL
End Date :
July 1 2006
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00417833
Start Date
December 1 2005
End Date
July 1 2006
Last Update
June 3 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.